Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$13.02 - $20.31 $651,000 - $1.02 Million
-50,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$16.88 - $20.83 $844,000 - $1.04 Million
50,000 New
50,000 $987,000
Q2 2019

Aug 14, 2019

SELL
$16.58 - $20.49 $2.58 Million - $3.19 Million
-155,555 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$16.7 - $21.52 $2.6 Million - $3.35 Million
155,555 New
155,555 $3.17 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.8B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.